Creative Planning Bridge Bio Pharma, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Creative Planning holds 31,264 shares of BBIO stock, worth $850,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,264

Holding current value

$850,068

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 11, 2024	BUY	$23.91 - $31.3 $747,522 - $978,563	31,264 New	31,264 $795,000
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $120,892 - $220,898	5,033 New	5,033 $203,000

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$687 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$683 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$386 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$338 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$165 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.03B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account